The role of mixed alkali metal cations on the formation of nanosized CHA zeolite from colloidal precursor suspension

A clear understanding of the crystal formation pathways of zeolites remains one of the most challenging issues to date. Here we investigate the synthesis of nanosized chabazite (CHA) zeolites using organic template-free colloidal suspensions by varying the time of aging at room temperature and the time of hydrothermal treatment at 90 °C. The role of mixed alkali metal cations (Na⁺, K⁺, Cs⁺) on the formation of CHA in the colloidal suspensions was studied. Increasing the aging time of the precursor colloidal suspension from 4 to 17 days resulted in faster crystallization of CHA nanocrystals (3 h instead of 7 h at 90 °C) to afford significantly smaller particles (60 nm vs 600 nm). During the crystallization a considerable change in the content of inorganic cations in the recovered solid material was observed to coincide with the formation of the CHA nanocrystals. The Na⁺ cations were found to direct the formation of condensed and pre-shaped aluminosilicate particles in the colloidal precursor suspensions, while K⁺ cations facilitated the formation of secondary building units (SBUs) of the CHA type framework structure such as d6r and cha cages, and the Cs⁺ cations promoted the long-range crystalline order facilitating the crystallization of stable zeolite nanocrystals.

Interzeolite conversion of a micronsized FAU to a nanosized CHA zeolite free of organic structure directing agent with a high CO2 capacity

The interzeolite transformation of a micronsized FAU zeolite to a nanosized CHA zeolite via alkali treatment is presented. The impact of the selection of the FAU zeolite starting material on the properties of the produced CHA zeolite was analyzed by XRD, ICP, SEM, TEM, N₂ and CO₂ adsorption, and in situ FT-IR. The analysis showed that the choice of starting FAU zeolite had a large impact on the chemical composition, size, morphology, and porosity of the produced CHA zeolite. The as prepared CHA samples show high capacity toward CO₂ (4.26 mmol g⁻¹) and it was demonstrated that the chemisorbed vs. physisorbed CO₂ was controlled by varying the amount of alkali cations in the CHA zeolite.

The interzeolite transformation of a micronsized FAU zeolite to a nanosized CHA zeolite via alkali treatment is presented.

COMT Val158Met and MTHFR C677T moderate risk of schizophrenia in response to childhood adversity

OBJECTIVE

Mesolimbic dopamine sensitization has been hypothesized to be a mediating factor of childhood adversity (CA) on schizophrenia risk. Activity of catechol-O-methyltransferase (COMT) Val158Met increases mesolimbic dopamine signaling and may be further regulated by methylenetetrahydrofolate reductase (MTHFR) C677T. This study investigates the three-way interaction between CA, COMT, and MTHFR.

METHODS

We conducted a nested case-control study on individuals born after 1981, linking population-based registers to study the three-way interaction. We included 1699 schizophrenia cases and 1681 controls, and used conditional logistic regression to report incidence rate ratios (IRRs).

RESULTS

Childhood adversity was robustly associated with schizophrenia. No main genetic effects were observed. MTHFR C677T increased schizophrenia risk in a dose-dependent manner per MTHFR T allele (P = 0.005) consequent upon CA exposure. After inclusion of the significant (P = 0.03) COMT × MTHFR × CA interaction, the risk was further increased per high-activity COMT Val allele. Hence, exposed COMT Val/Val and MTHFR T/T carriers had an IRR of 2.76 (95% CI, 1.66-4.61). Additional adjustments for ancestry and parental history of mental illness attenuated the results with the interaction being only marginally significant.

CONCLUSION

MTHFR C677T and COMT Val158Met interact with CA to increase risk of schizophrenia.

Human platelet antigen frequencies of platelet donors in the French population determined by polymerase chain reaction with sequence-specific primers

To prevent human platelet alloimmunization, Blood Transfusion Centres have to develop a strategy close to the erythrocytes' one. The first step of this strategy is to perform the HPA typing of donors with an accurate method. We applied the PCR-SSP to type 800 platelet donors in the HPA-1 and HPA-5 systems and 350 in the HPA-2 and HPA-3 ones. This study reports the human platelet antigen frequencies of four platelet-specific alloantigen systems in the French population. The results are quite similar to those currently published for Caucasian population frequencies. Low prevalences are observed for the HPA-1b, (2%), HPA-2b (0.6%) and HPA-5b (2%) groups. Furthermore, this study confirms the need to type donors and recipients in the HPA-1 system at least, in case of post-transfusion pupura and platelet refractoriness to platelet transfusion therapy.

Peripheral blood stem cells harvested after chemotherapy and GM-CSF for treatment intensification in patients with advanced lymphoproliferative diseases

Peripheral blood stem cells (PBSC) from 15 patients with advanced non-Hodgkin's lymphoma (NHL), two patients with chronic lymphocytic leukemia, and two patients with myeloma were collected by continuous-flow leukapheresis after chemotherapy with MIV (mitoxantrone, ifosfamide, and etoposide, five patients) or high-dose cyclophosphamide (14 patients), followed by administration of GM-CSF. Sixteen patients (84%) had persistent marrow involvement at time of inclusion. Results were compared to those obtained in a control group of similar age and disease status in whom collection had been performed after MIV chemotherapy alone. The number of mononuclear cells, granulocyte-macrophage colony-forming units (CFU-GM), CD34+ cells were higher in GM-CSF treated patients with a lower mean number of leukapheresis (3.5 versus 6.4). Among the 19 patients harvested after chemotherapy plus GM-CSF, more progenitor cells were obtained in the cyclophosphamide group than in the MIV group. In all these patients except one, the number of mononuclear cells was sufficient to realize a transplantation. Seventeen patients received intensification with BEAM regimen (8 patients) or cyclophosphamide plus etoposide and total body irradiation (9 patients). Two patients failed to reconstitute correct hematopoiesis and three early toxic deaths occurred for a total of five procedure-related deaths. Nine of these 17 patients are in persistent complete remission with a median post-transplant follow-up of 18 months. Time to reach granulocyte and platelet recovery was not correlated with the number of mononuclear cells, CFU-GM, granulocyte-erythroid-macrophage-megakaryocyte colony-forming units (CFU-GEMM), CD34+ cells, and CD34+ CD33- cells but with the number of previous chemotherapy regimens. PBSC harvesting is achievable after chemotherapy plus GM-CSF in heavily pretreated patients with persistent marrow involvement. Moreover, these cells are able to reconstitute correct hematopoiesis after intensive treatment in these patients.